CN116120332A - Synthesis method of racemized camptothecin intermediate tricyclic compound - Google Patents

Synthesis method of racemized camptothecin intermediate tricyclic compound Download PDF

Info

Publication number
CN116120332A
CN116120332A CN202310208354.4A CN202310208354A CN116120332A CN 116120332 A CN116120332 A CN 116120332A CN 202310208354 A CN202310208354 A CN 202310208354A CN 116120332 A CN116120332 A CN 116120332A
Authority
CN
China
Prior art keywords
compound
formula
reaction
acid
synthesizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310208354.4A
Other languages
Chinese (zh)
Inventor
叶伟平
夏纪宝
蹇锋
吴洋
罗岳雷
陈凯
张越锋
李忠海
张路
谭雪华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Raffles Pharmatech Co ltd
Original Assignee
Guangdong Raffles Pharmatech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Raffles Pharmatech Co ltd filed Critical Guangdong Raffles Pharmatech Co ltd
Priority to CN202310208354.4A priority Critical patent/CN116120332A/en
Publication of CN116120332A publication Critical patent/CN116120332A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention relates to a synthesis method of a racemized camptothecin intermediate tricyclic compound, which belongs to the field of organic chemical synthesis, and aims to overcome the defects that raw materials for synthesizing 4-ethyl-7, 8-dihydro-IH-pyrano [3,4-f ] indene-3, 6, 10 (4H) -trione are expensive and difficult to produce and amplify, and the like. The reaction involved in the invention is mostly conventional reaction, the reaction condition is mild, and compared with the former process, the complexity of the reaction is reduced and the safety is reduced; the used materials are cheaper, the yield of the technological process is improved, and the total cost is reduced; and the synthesis route is short, the yield is high, and the process is easy to purify.

Description

Synthesis method of racemized camptothecin intermediate tricyclic compound
Technical Field
The invention belongs to the field of organic chemical synthesis, and particularly relates to a synthesis method of a racemized camptothecin intermediate tricyclic compound, namely a synthesis method of 4-ethyl-7, 8-dihydro-IH-pyrano [3,4-f ] indene-3, 6, 10 (4H) -trione.
Background
Camptothecins (r1=r2=h, camptothecin, CPT) were one containing quinoline pentacyclic skeleton structure isolated in 1966 from camptothecins of the family daviaceae in the middle of china for the first time by us Wall et al (Wall M E, wani M C, cook C E et al j Am Chem soc.1966,88, 3888-3890). Since it shows remarkable antitumor activity in animal experiments in vivo and in vitro, it becomes one of the key points of the research of antitumor drugs . The development of these compounds has entered a rapid development stage after the discovery of a unique mechanism of action in which camptothecin is a specific inhibitor of topoisomerase I from Hsiang et al (Hsiang Y H, hertzberg R, hertt S et al J Bio chem.1985,260, 14873-14878).
The efficient chemical total synthesis of camptothecins and derivatives thereof has been one of the hot spots in the field of pharmaceutical chemistry research for over twenty years, and various research groups at home and abroad have reported a total synthesis route of over 30 camptothecins and analogues thereof in succession (Du W. Tetrahedron,2003, 59:5120). In a plurality of synthetic strategies, friedlander condensation method is to condense an A ring and a CDE ring to obtain camptothecin, which has unique advantages in structural modification of the camptothecin, the CDE ring of the camptothecin can be obtained by chiral resolution of a racemized CDE ring at present, and the racemized camptothecin and derivatives thereof are also important reference substances for testing the biological activity of the camptothecin.
There are three routes for the racemic CDE ring synthesis of camptothecins, but these routes all have some problems:
1) J.Med. Chem.1980,23,554-560 provides the following synthetic routes:
Figure BDA0004111670010000021
the route has the following disadvantages: 1. the yields of the first step and the fourth step are low, and the reaction time of the first step is too long; 2. raney nickel used in the reaction process is relatively complex to process; 3. the ethylation reaction needs low-temperature operation, and the reaction time is long; 4. the starting material ethyl 5-cyano-4-methyl-6-oxo-1, 6-dihydropyridine-2-carboxylate is expensive.
2) J.0rg.chem.l993,58,611-617 provides the following synthetic routes:
Figure BDA0004111670010000022
the disadvantages of this route are as follows: 1. the yield of hydrobromic acid decarboxylation in this process is too low; 2. the oxidation conditions are harsh and the yield is low; 3. waste with higher toxicity can be generated in the reaction process, so that the cost for treating the waste is increased; 4. the cost of the initial raw material alkenyl chloride is high.
3) Current Organic Synthesis 2020,17,5880591 provides the following synthetic route:
Figure BDA0004111670010000031
the route has the following disadvantages: 1. the price of the initial raw materials used for synthesis is high; 2. the transition metal catalysts are expensive in the reaction process; 3. the toxic gas carbon monoxide is used in the reaction process, which is unfavorable for mass production.
In conclusion, the current synthetic route for synthesizing the key intermediate tricyclic compound of the antitumor drug camptothecin, namely 4-ethyl-7, 8-dihydro-IH-pyrano [3,4-f ] indene-3, 6, 10 (4H) -trione, has larger optimization space and development potential from the aspects of cost and production feasibility.
Disclosure of Invention
Aiming at the problems of low safety, low yield, high raw material cost and the like of the existing synthetic 4-ethyl-7, 8-dihydro-IH-pyrano [3,4-f ] indene-3, 6, 10 (4H) -trione route, the invention provides a novel method for synthesizing 4-ethyl-7, 8-dihydro-IH-pyrano [3,4-f ] indene-3, 6, 10 (4H) -trione.
The specific technical scheme is as follows:
1) Adding a chloro reagent (1.1-1.2 mol) and methylene dichloride into a reaction kettle, cooling to 0-5 ℃ under the protection of nitrogen, keeping the temperature, dropwise adding a compound (1.0 mol) of the formula 1 in the following reaction line, continuously dropwise adding triethylamine (15-18 mol) under the stirring of 0-5 ℃ after the dropwise adding, and stirring at 25-30 ℃ for reacting for 1.5h; adding dichloromethane for extraction, and concentrating the organic phase after merging; concentrating, filtering the concentrate with a silica gel-filled sand core funnel, eluting with petroleum ether and ethyl acetate mixture (PE/EA=5/1), and concentrating the filtrate to obtain the compound of formula 3.
2) Adding a compound (1.0 mol) of formula 2 into a reaction kettle, adding toluene, adding dimethyl sulfate (1.0-1.1 mol), stirring at 80-90 ℃ for reaction for 12 hours, and adding amine (1.1-1.2 mol) and a compound (1.0 mol) with active methylene; distilling to remove toluene, adding methanol, adding sodium methoxide, refluxing and stirring to react for 2h, distilling to remove methanol, cooling to room temperature, adding ice water into a bottle, and regulating pH to 5-6 with hydrochloric acid solution; extracting the organic phase with dichloromethane, drying with anhydrous sodium sulfate, concentrating, and recrystallizing with petroleum ether to obtain compound of formula 4;
3) Adding a compound (1.0 mol) of formula 3, a compound (0.75-0.80 mol) of formula 4, amine (5.0-6.0 mol) and ethanol into a reaction kettle, and reacting for 12 hours at 25-30 ℃; filtering the reaction solution, and washing a filter cake with petroleum ether to obtain a compound of formula 5;
4) Adding a compound (1.0 mol) of formula 5 and ethylene glycol dimethyl ether into a reaction kettle, cooling to 0-5 ℃, adding potassium tert-butoxide (1.0-1.1 mol), reacting for 30min, adding an ethylation reagent (1.8-2.0 mol), and reacting for 6h at 25-30 ℃; the reaction is extracted by methylene dichloride, the organic phase is dried by anhydrous sodium sulfate and concentrated to obtain the compound of formula 6;
5) Adding a compound (1.0 mol), 1, 4-dioxane, paraformaldehyde (2.0-2.5 mol), acid (0.02-0.025 volume ratio) and water (0.2-0.25 volume ratio) in an autoclave, and reacting for 24 hours at 105-107 ℃; the reaction is extracted by methylene dichloride, the organic phase is dried by anhydrous sodium sulfate and concentrated to obtain the compound of formula 7;
6) Adding a compound (1.0 mol) of formula 7, benzaldehyde (1.0-1.1 mol), a mixed solvent of a catalyst, DMF and THF into a reaction kettle, cooling at-40 ℃ to-50 ℃ and stirring for 10 minutes, adding lithium bis (trimethylsilyl) amide (1.1-1.2 mol), reacting at room temperature for 24 hours, adding a hydrochloric acid solution, stirring for 2 hours, adjusting the pH value to 5-6, and extracting with the mixed solvent of dichloromethane and methanol. The organic phase is dried with anhydrous sodium sulfate, filtered and concentrated; adding the concentrated dry matter into an acid solution, and reacting for 3 hours at 90+/-2 ℃; adding sodium carbonate for neutralization, extracting dichloromethane in the reaction liquid, drying an organic phase by using anhydrous sodium sulfate, and concentrating to obtain a compound shown in a formula 8;
7) Adding a compound (1.0 mol) of formula 8, dichloromethane and methanol solution into a reaction kettle, cooling to-70 ℃ to-75 ℃ and introducing peroxide for 10-30min; introducing oxygen for 10min, adding dimethyl sulfide (1.0 mol), and reacting at 25-30deg.C for 2h; the reaction is extracted by methylene dichloride, the organic phase is dried by anhydrous sodium sulfate and concentrated to obtain the compound of formula 9;
8) Adding a mixed solvent of a compound (1.0 mol) of formula 9, ethylene glycol (2.5-3.0 mol), DCE and DMF into a reaction kettle, dropwise adding acid (1.0-1.1 mol) under stirring at 0-5 ℃, stirring at 80-85 ℃ after the dropwise adding is finished for reaction for 5 hours, adding a 10% sodium carbonate solution into the reaction solution for washing, extracting with dichloromethane, drying an organic phase with anhydrous sodium sulfate, and concentrating to obtain the compound of formula 10.
Preferred embodiments of the invention:
the chlorinating reagent required in the step 1) can be selected from 2-chloro-1, 3-dimethyl imidazoline chloride, thionyl chloride, phosphorus oxychloride and the like, and preferably 2-chloro-1, 3-dimethyl imidazoline chloride;
the compound having an active methylene group required in step 2) may be selected from isopropylidene malonate, β -keto ester, preferably isopropylidene malonate; the required amine can be selected from triethylamine, 1, 8-diazo hetero double spiro [5.4.0] undec-7-ene and the like, and is preferably triethylamine;
the amine required in step 3) can be selected from dimethyl ethylenediamine, triethylamine, and the like, preferably triethylamine;
the ethylation reagent required in the step 4) can be selected from ethyl iodide, ethyl bromide and the like, and ethyl iodide is preferred;
the acid required for the hydrolysis in the step 5) can be selected from concentrated sulfuric acid, concentrated hydrochloric acid and the like, and the concentrated sulfuric acid is preferred;
step 6) the catalyst can be tetrabutylammonium bromide, triethylbenzyl ammonium bromide and the like, preferably triethylbenzyl ammonium bromide; the acid for decarboxylation may be hydrobromic acid, hydrochloric acid, sulfuric acid, etc., preferably hydrobromic acid;
the peroxide in the step 7) can be selected from hydrogen peroxide, potassium permanganate, ozone and the like, and ozone is preferred.
The acid required for glycol protection in step 8) can be selected from p-toluenesulfonic acid, trimethylchlorosilane and the like. Trimethylchlorosilane is preferred.
A typical reaction scheme of the invention is as follows:
Figure BDA0004111670010000051
the invention has the beneficial effects that: the related reactions are mostly conventional reactions, the reaction conditions are mild, and compared with the former process, the complexity and the safety of the reactions are reduced; the used materials are cheaper, the yield of the technological process is improved, and the total cost is reduced; and the synthesis route is short, the yield is high, and the process is easy to purify.
Detailed Description
(1) Synthesis of diene esters
2-chloro-1, 3-dimethylimidazoline chloride (12, 0g,72 mmol) was added to the reaction flask, methylene chloride (600 mL) was added, dimethyl 1, 3-acetonedicarboxylic acid ester (10.0 g,8.6mL,60 mmol) was added under stirring at 0℃and triethylamine (18.1 g,25mL, 178 mmol) was slowly added dropwise under stirring at 0℃and the reaction mixture was stirred at room temperature (25 ℃) for 1.5 hours after the addition. The aqueous phase was extracted with dichloromethane (100 mL), the organic phases combined and concentrated, the concentrate filtered through a sand core funnel with silica gel and rinsed with a mixture of petroleum ether and ethyl acetate (900 mL, pe/ea=5/1). The leacheate was concentrated to give yellow liquid 1 in 75% yield.
(2) Knovenagel condensation
2-pyrrolidone (50.0 g,0.6 mol) was added to the reaction flask, toluene (1L) was added, dimethyl sulfate (75.7 g,0.6 mol) was added, and the mixture was stirred at 90℃for reaction for 12 hours. Triethylamine (68.8 g,95mL,0.68 mol) was slowly added to the reaction system, followed by Mirabilitic acid (86.5 g,0.6 mol) was slowly added thereto, and after stirring and reaction at 90℃for 12 hours, toluene was distilled off. Subsequently methanol (1L) was added, sodium methoxide (64.9 g,1.2 mol) was added, and after stirring under reflux for 2 hours, methanol was distilled off. After the reaction cooled to room temperature, ice water was added to the flask and the pH was adjusted to 5-6 with 2N hydrochloric acid solution. The organic phase was extracted with DCM (500 mL), dried over Na2SO4, concentrated and recrystallized from petroleum ether (100 mL) to give 42.0g of product (2) in 51% yield.
(3) Condensation
A100 mL round bottom flask was charged with yellow liquid 1 (7.0 g,45 mmol), product (2) (5 g,35 mmol), et3N (triethylamine, 0.3mL,2.45 mmol) and EtOH (50 mL), reacted at 25℃for 12h with stirring, TLC detected A07 as no residue, the solid in the system was directly filtered and washed with petroleum ether (50 mL) to give a white solid as 8.2g of product (3) in 89% yield.
(4) Ethylation reaction
To the reaction flask was added the product (3) (16.8 g,63 mmol), ethylene glycol dimethyl ether (250 mL), and potassium tert-butoxide (7.5 g,67 mmol) was added under cooling and stirring at 0℃and the reaction was stirred for 30min. Iodoethane (19.8 g,10mL,127 mmol) was added, the reaction was allowed to return to room temperature (25 ℃ C.) with stirring for 6h, GCMS was complete, extracted with DCM (300 mL), and the organic phase was dried over anhydrous sodium sulfate. Concentration gave (4) as a pale yellow solid (18.0 g) in 100% yield.
(5) Closing ring
Compound (4) (18.0 g,63 mmol) was dissolved in 1, 4-dioxane (95 mL) and added to a sealed, thick-walled pressure-resistant bottle. Paraformaldehyde (11.3 g,126 mmol), concentrated sulfuric acid (3.7 mL), and water (3.7 mL) were then added sequentially. The thick-wall pressure-resistant bottle is screwed tightly, and the reaction is stirred for 24 hours at 107 ℃ (the reaction bottle is placed behind the explosion-proof baffle for reaction). TLC and GCMS showed that the reaction was complete as pale yellow solid (4). Extraction with DCM (200 mL) and drying of the organic phase over anhydrous MgSO4, filtration and concentration gave the crude product as a yellow liquid (5) 18.0g in 100% yield.
(6) Alkylation and decarboxylation
In the reaction flask, yellow liquid (5) (15.0 g,52 mmol), benzaldehyde (5.5 g,52 mmol), triethylbenzyl ammonium bromide (283 mg,1.0 mmol), a mixed solvent of DMF and THF (104 ml, DMF/thf=1/1) were added sequentially. Cooled down at-40 ℃ and stirred for 10 minutes, lithium bis (trimethylsilyl) amide (62.4mL,62.4mmol,1M in THF) was added, the reaction was carried out at room temperature for 24 hours, and after the reaction was completed, hydrochloric acid solution (21 ml,6 m) was added and stirring was continued for 2 hours. The pH was adjusted to 5-6, and the mixture was extracted with a mixed solvent of methylene chloride (600 mL) and methanol (60 mL). The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to give the crude carboxylic acid compound.
The crude carboxylic acid was added to an aqueous solution of hydrobromic acid (50 mL, 40%) and reacted at 90℃for 3h. After completion of the reaction, hydrobromic acid was neutralized with saturated sodium carbonate until no bubbles were formed, and the reaction mixture was extracted with methylene chloride (500 mL). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated to give 16.0g of crude product (6) in 96% yield.
(7) Debenzylation
In a reaction flask, crude product (6) (3.0 g,9.3 mmol), dichloromethane and 93mL (1:1) of methanol solution were added sequentially. Ozone is introduced at-70 ℃ for 10-30 minutes (until the solid in the system disappears and the system is clear), TLC detection (6) is carried out, and oxygen is introduced for 10 minutes. Dimethyl sulfide (578 mg,9.3 mmol) was added after aeration was complete, and then reacted at room temperature for 2h. After the reaction was completed, TLC detected that the reaction was completely oxidized, extracted with dichloromethane (20 mL), dried over anhydrous sodium sulfate, concentrated and spin-dried column chromatography (eluent=ea) to give the target product as pale yellow (7) 1.7g in 74% yield.
(8) Glycol protection
In a reaction flask, the desired product was added light yellow (7) (124.0 mg,0.5 mmol), ethylene glycol (102.4 mg,1.65 mmol), a mixed solvent of dichloroethane and N, N-dimethylformamide (2 ml, dce: dmf=36:1) in sequence. Trimethylchlorosilane (0.5 mmol,54.3 mg) was added dropwise with stirring at 0deg.C, and the mixture was reacted at 80deg.C for 5 hours. After the reaction, 10% sodium carbonate solution was added for washing, followed by extraction with methylene chloride (50 mL), drying over anhydrous sodium sulfate and concentration to give 146.0mg of 4-ethyl-7, 8-dihydro-IH-pyrano [3,4-f ] indene-3, 6, 10 (4H) -trione in 65% yield.

Claims (9)

1. A method for synthesizing a racemic camptothecin intermediate tricyclic compound, which is characterized by comprising the following steps:
1) Adding a chloro reagent and dichloromethane into a reaction kettle, cooling to 0-5 ℃ under the protection of nitrogen, keeping the temperature, dropwise adding a compound of formula 1, continuously dropwise adding triethylamine under the stirring of 0-5 ℃ after the dropwise adding, stirring and reacting at 25-30 ℃ after the dropwise adding is finished, adding dichloromethane for extraction, and concentrating after the organic phases are combined; concentrating and filtering, leaching the concentrate by using a mixed solution of petroleum ether and ethyl acetate, and concentrating the filtrate to obtain a compound shown in a formula 3;
2) Adding a compound of formula 2 into a reaction kettle, adding toluene, adding dimethyl sulfate, stirring at 80-90 ℃ for reaction, and then adding amine and a compound with active methylene; distilling to remove toluene, adding methanol, adding sodium methoxide, refluxing and stirring to react for 2h, distilling to remove methanol, cooling to room temperature, adding ice water into a bottle, and regulating pH to 5-6 with hydrochloric acid solution; extracting the organic phase with dichloromethane, drying and concentrating with anhydrous sodium sulfate, and recrystallizing with petroleum ether to obtain a compound shown in formula 4;
3) Adding a compound of formula 3, a compound of formula 4, amine and ethanol into a reaction kettle, and reacting at 25-30 ℃; filtering the reaction solution, and washing a filter cake with petroleum ether to obtain a compound of formula 5;
4) Adding a compound shown in the formula 5 and ethylene glycol dimethyl ether into a reaction kettle, cooling to 0-5 ℃, adding potassium tert-butoxide, reacting, adding an ethylation reagent, and continuing to react at 25-30 ℃; the reaction is extracted by methylene dichloride, the organic phase is dried by anhydrous sodium sulfate and concentrated to obtain the compound of formula 6;
5) Adding a compound of formula 6, 1, 4-dioxane, paraformaldehyde, acid and water into an autoclave, and reacting at 105-107 ℃; the reaction is extracted by methylene dichloride, the organic phase is dried by anhydrous sodium sulfate and concentrated to obtain the compound of formula 7;
6) Adding a mixed solvent of a compound of formula 7, benzaldehyde, a catalyst, DMF and THF into a reaction kettle, cooling and stirring at-40 ℃ to-50 ℃, adding lithium bis (trimethylsilyl) amide, reacting at room temperature, adjusting the pH value to 5-6, and extracting with a mixed solvent of dichloromethane and methanol. The organic phase is dried with anhydrous sodium sulfate, filtered and concentrated; adding the concentrated dry matter into an acid solution, and reacting at 90+/-2 ℃; adding sodium carbonate for neutralization after the reaction, extracting methylene dichloride in the reaction liquid, drying an organic phase by using anhydrous sodium sulfate, and concentrating to obtain a compound of formula 8;
7) Adding a compound of formula 8, dichloromethane and methanol solution into a reaction kettle, cooling to-70 ℃ to-75 ℃ and introducing peroxide; introducing oxygen, adding dimethyl sulfide, and reacting at 25-30deg.C; the reaction is extracted by methylene dichloride, the organic phase is dried by anhydrous sodium sulfate and concentrated to obtain the compound of formula 9;
8) Adding a mixed solvent of the compound of formula 9, ethylene glycol, DCE and DMF into a reaction kettle, dropwise adding acid under stirring at 0-5 ℃, stirring at 80-85 ℃ for reaction after the dropwise adding, adding 10% sodium carbonate solution into the reaction solution for washing, extracting with dichloromethane, drying an organic phase with anhydrous sodium sulfate, and concentrating to obtain the compound of formula 10.
2. The method for synthesizing a racemic camptothecin intermediate tricyclic compound according to claim 1, wherein the chlorinating agent required in step 1) is selected from the group consisting of 2-chloro-1, 3-dimethylimidazoline chloride, thionyl chloride and phosphorus oxychloride.
3. The method of synthesizing a racemic camptothecin intermediate tricyclic compound according to claim 1, wherein the compound having an active methylene group required in step 2) is selected from isopropylidene malonate, malonate or β -keto ester.
Or the required amine can be triethylamine, 1, 8-diazabicyclo [5.4.0] undec-7-ene.
4. The method of synthesizing a racemic camptothecin intermediate tricyclic compound according to claim 1, wherein the amine required in step 3) is selected from the group consisting of dimethylethylenediamine and triethylamine.
5. The method of synthesizing a racemic camptothecin intermediate tricyclic compound according to claim 1, wherein the ethylating reagent required in step 4) is selected from the group consisting of ethyl iodide and ethyl bromide.
6. The method for synthesizing the racemic camptothecin intermediate tricyclic compound according to claim 1, wherein the acid required for the hydrolysis in the step 5) is selected from concentrated sulfuric acid and concentrated hydrochloric acid.
7. The method of synthesizing a racemic camptothecin intermediate tricyclic compound according to claim 1, wherein the catalyst of step 6) is selected from tetrabutylammonium bromide or triethylbenzyl ammonium bromide;
or the acid used for decarboxylation is selected from hydrobromic acid, hydrochloric acid or sulfuric acid.
8. The method of synthesizing a racemic camptothecin intermediate tricyclic compound according to claim 1, wherein step 7) peroxide is selected from hydrogen peroxide, potassium permanganate, or ozone.
9. The method of synthesizing a racemic camptothecin intermediate tricyclic compound according to claim 1, wherein the acid required for ethylene glycol protection in step 8) is selected from p-toluenesulfonic acid or trimethylchlorosilane.
CN202310208354.4A 2023-03-07 2023-03-07 Synthesis method of racemized camptothecin intermediate tricyclic compound Pending CN116120332A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310208354.4A CN116120332A (en) 2023-03-07 2023-03-07 Synthesis method of racemized camptothecin intermediate tricyclic compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310208354.4A CN116120332A (en) 2023-03-07 2023-03-07 Synthesis method of racemized camptothecin intermediate tricyclic compound

Publications (1)

Publication Number Publication Date
CN116120332A true CN116120332A (en) 2023-05-16

Family

ID=86310143

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310208354.4A Pending CN116120332A (en) 2023-03-07 2023-03-07 Synthesis method of racemized camptothecin intermediate tricyclic compound

Country Status (1)

Country Link
CN (1) CN116120332A (en)

Similar Documents

Publication Publication Date Title
IE832956L (en) SUBSTITUTED 5H-PYRIMIDO £5,4-b| INDOLES
CN110845428B (en) Photocatalytic preparation method of 3-acyl quinoxalinone compound
AU785385B2 (en) Novel derivatives and analogues of galanthamin
WO1994029310A1 (en) Process for asymmetric total synthesis of camptothecin
Kuehne et al. Total syntheses of tubotaiwine and 19, 20-dihydro-20-epi-akuammicine
JPS63165387A (en) Production of (+)-biotin
Potewar et al. Synthesis of tryptanthrin and deoxyvasicinone by a regioselective lithiation-intramolecular electrophilic reaction approach
CN116120332A (en) Synthesis method of racemized camptothecin intermediate tricyclic compound
CN111732594B (en) Preparation method of fluxaparide
CN101885697A (en) Preparation method of Oxiracetam, product of Oxiracetam and use of product
CN113912609B (en) Preparation method of natural alkaloid tryptanthrin and derivatives thereof
CN104761557B (en) Hexahydro-1H-pyrrolo[3,4-d]pyrimidine compound and preparation method thereof
CN109851599B (en) Preparation method of 2-aminobenzofuran compound
Mamouni et al. Synthesis and reactivity of oxopyrrolidinothieno [2] azepinones:[3] Benzazepine antidepressant analogs
CN103342707A (en) Preparation method for preparing asenapine intermediate
Sutherland et al. The chemistry of polyazaheterocyclic compounds. Part VII. Extensions of av-triazolo [1, 5-a] quinazoline synthesis and a new route to 4-aminoquinazoline derivatives
Tong et al. Reaction of tetrachloropyrazine with active methylene compounds
CN116253675B (en) Synthesis method of N-substituted-2-piperidone
Chang et al. Synthesis of fused bicyclic glutarimides
CN115417803B (en) Synthesis method of Wu Pa tenib intermediate (3R, 4S) -1-benzyloxycarbonyl-4-ethylpyrrolidine-3-carboxylic acid
CN115611901B (en) Azepine compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof
CN113387804B (en) Synthesis method of alpha-asarone acetate and alpha-octanol
CN107602439B (en) Synthetic method for preparing marine alkaloid Baculiferin-L intermediate
CN112142663B (en) Synthesis method of (S) -1-phenyl-1, 2,3, 4-tetrahydroisoquinoline
Elliott Jr Synthesis of (.+-.)-o-methylcryptaustoline iodide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination